IBDEI0KC ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1174,0)
 ;;=AUDITORY^4^127
 ;;^UTILITY(U,$J,358.4,1175,0)
 ;;=COGNITION^8^127
 ;;^UTILITY(U,$J,358.4,1176,0)
 ;;=PSYCHIATRIC-PSYCHOSOC-EMOTIONAL^17^127
 ;;^UTILITY(U,$J,358.4,1177,0)
 ;;=BACK DIAGNOSIS^5^127
 ;;^UTILITY(U,$J,358.4,1178,0)
 ;;=EXTREMITY DIAGNOSIS^10^127
 ;;^UTILITY(U,$J,358.4,1179,0)
 ;;=POST JOINT REPLACEMENT^16^127
 ;;^UTILITY(U,$J,358.4,1180,0)
 ;;=OTHER^14^127
 ;;^UTILITY(U,$J,358.4,1181,0)
 ;;=INITIAL EVAL FOR TBI^1^128
 ;;^UTILITY(U,$J,358.4,1182,0)
 ;;=NEW PATIENT^2^129
 ;;^UTILITY(U,$J,358.4,1183,0)
 ;;=ESTABLISHED PATIENT^1^129
 ;;^UTILITY(U,$J,358.4,1184,0)
 ;;=CONSULTATIONS^3^129
 ;;^UTILITY(U,$J,358.4,1185,0)
 ;;=GLOBAL FOLLOW UP^4^129
 ;;^UTILITY(U,$J,358.4,1186,0)
 ;;=OFFICE PROCEDURES^0^130
 ;;^UTILITY(U,$J,358.4,1187,0)
 ;;=DIAGNOSIS^1^131
 ;;^UTILITY(U,$J,358.4,1188,0)
 ;;=NEW PATIENT^2^132
 ;;^UTILITY(U,$J,358.4,1189,0)
 ;;=ESTABLISHED PATIENT^1^132
 ;;^UTILITY(U,$J,358.4,1190,0)
 ;;=CONSULTATIONS^3^132
 ;;^UTILITY(U,$J,358.4,1191,0)
 ;;=NEURO^5^133
 ;;^UTILITY(U,$J,358.4,1192,0)
 ;;=MENTAL HEALTH^4^133
 ;;^UTILITY(U,$J,358.4,1193,0)
 ;;=HISTORY OF ILLNESS^3^133
 ;;^UTILITY(U,$J,358.4,1194,0)
 ;;=PREVENTIVE HEALTH/SCREENINGS^6^133
 ;;^UTILITY(U,$J,358.4,1195,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^7^133
 ;;^UTILITY(U,$J,358.4,1196,0)
 ;;=OTHER REASONS^8^133
 ;;^UTILITY(U,$J,358.4,1197,0)
 ;;=TBI SCREENING^1^133
 ;;^UTILITY(U,$J,358.4,1198,0)
 ;;=CAUSES OF INJURY (SECONDARY DX ONLY)^9^133
 ;;^UTILITY(U,$J,358.4,1199,0)
 ;;=HEADACHES^2^133
 ;;^UTILITY(U,$J,358.4,1200,0)
 ;;=PROCEDURES^1^134
 ;;^UTILITY(U,$J,358.4,1201,0)
 ;;=PT/KT/OT^2^134
 ;;^UTILITY(U,$J,358.4,1202,0)
 ;;=TESTING^3^134
 ;;^UTILITY(U,$J,358.4,1203,0)
 ;;=NEW PATIENT^2^135
 ;;^UTILITY(U,$J,358.4,1204,0)
 ;;=ESTABLISHED PATIENT^1^135
 ;;^UTILITY(U,$J,358.4,1205,0)
 ;;=PREVENTIVE MEDICINE^5^135
 ;;^UTILITY(U,$J,358.4,1206,0)
 ;;=PREVENTIVE COUNSELING^4^135
 ;;^UTILITY(U,$J,358.4,1207,0)
 ;;=IMMUNIZATION^6^136
 ;;^UTILITY(U,$J,358.4,1208,0)
 ;;=INJECTION^7^136
 ;;^UTILITY(U,$J,358.4,1209,0)
 ;;=SKIN TEST^11^136
 ;;^UTILITY(U,$J,358.4,1210,0)
 ;;=NURSING PROCEDURES^9^136
 ;;^UTILITY(U,$J,358.4,1211,0)
 ;;=MINOR PROCEDURES^8^136
 ;;^UTILITY(U,$J,358.4,1212,0)
 ;;=SPLINTS^12^136
 ;;^UTILITY(U,$J,358.4,1213,0)
 ;;=EDUCATION/TRAINING^3^136
 ;;^UTILITY(U,$J,358.4,1214,0)
 ;;=ALLERGY SHOTS^1^136
 ;;^UTILITY(U,$J,358.4,1215,0)
 ;;=EKG^4^136
 ;;^UTILITY(U,$J,358.4,1216,0)
 ;;=BEHAVIORAL CHANGE INTERVENTION^2^136
 ;;^UTILITY(U,$J,358.4,1217,0)
 ;;=OTH PREVENTIVE MEDICINE SVCS^10^136
 ;;^UTILITY(U,$J,358.4,1218,0)
 ;;=GYN PROCEDURES^5^136
 ;;^UTILITY(U,$J,358.4,1219,0)
 ;;=CARDIOVASCULAR^2^137
 ;;^UTILITY(U,$J,358.4,1220,0)
 ;;=ENDOCRINE/METABOLIC^5^137
 ;;^UTILITY(U,$J,358.4,1221,0)
 ;;=PULMONARY^19^137
 ;;^UTILITY(U,$J,358.4,1222,0)
 ;;=EENT^4^137
 ;;^UTILITY(U,$J,358.4,1223,0)
 ;;=MUSCULOSKELETAL^13^137
 ;;^UTILITY(U,$J,358.4,1224,0)
 ;;=NEURO^14^137
 ;;^UTILITY(U,$J,358.4,1225,0)
 ;;=MENTAL HEALTH^12^137
 ;;^UTILITY(U,$J,358.4,1226,0)
 ;;=GASTROENTEROLOGY^6^137
 ;;^UTILITY(U,$J,358.4,1227,0)
 ;;=GU / RENAL^7^137
 ;;^UTILITY(U,$J,358.4,1228,0)
 ;;=WOMEN'S HEALTH^22^137
 ;;^UTILITY(U,$J,358.4,1229,0)
 ;;=HEMATOLOGY/ONCOLOGY^8^137
 ;;^UTILITY(U,$J,358.4,1230,0)
 ;;=INFECTIOUS DISEASE^10^137
 ;;^UTILITY(U,$J,358.4,1231,0)
 ;;=DERMATOLOGY^3^137
 ;;^UTILITY(U,$J,358.4,1232,0)
 ;;=HISTORY OF ILLNESS^9^137
 ;;^UTILITY(U,$J,358.4,1233,0)
 ;;=PREVENTIVE HEALTH/SCREENINGS^17^137
 ;;^UTILITY(U,$J,358.4,1234,0)
 ;;=INJURY/TRAUMA^11^137
 ;;^UTILITY(U,$J,358.4,1235,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^21^137
 ;;^UTILITY(U,$J,358.4,1236,0)
 ;;=SEXUAL TRAUMA^20^137
 ;;^UTILITY(U,$J,358.4,1237,0)
 ;;=PAIN^16^137
 ;;^UTILITY(U,$J,358.4,1238,0)
 ;;=OTHER REASONS^15^137
 ;;^UTILITY(U,$J,358.4,1239,0)
 ;;=COMMON DIAGNOSES^1^137
 ;;^UTILITY(U,$J,358.4,1240,0)
 ;;=PREVENTIVE MEDICINE CODES^18^137
 ;;^UTILITY(U,$J,358.4,1241,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^.5^137
 ;;^UTILITY(U,$J,358.4,1242,0)
 ;;=NEW PATIENT^2^138
 ;;^UTILITY(U,$J,358.4,1243,0)
 ;;=ESTABLISHED PATIENT^1^138
 ;;^UTILITY(U,$J,358.4,1244,0)
 ;;=COUNSELING RISK FACTOR REDUCTION^3^138
 ;;^UTILITY(U,$J,358.4,1245,0)
 ;;=PREVENTIVE MEDICINE,GROUP COUNSELING^4^138
 ;;^UTILITY(U,$J,358.4,1246,0)
 ;;=OTH PREVENTIVE MEDICINE SERVICES^5^138
 ;;^UTILITY(U,$J,358.4,1247,0)
 ;;=IMMUNIZATION^2^139
 ;;^UTILITY(U,$J,358.4,1248,0)
 ;;=BEHAVIOR CHANGE INTERVENTION,INDIVIDUAL^1^139
 ;;^UTILITY(U,$J,358.4,1249,0)
 ;;=CARDIOVASCULAR^2^140
 ;;^UTILITY(U,$J,358.4,1250,0)
 ;;=ENDOCRINE/METABOLIC^6^140
 ;;^UTILITY(U,$J,358.4,1251,0)
 ;;=PULMONARY^19^140
 ;;^UTILITY(U,$J,358.4,1252,0)
 ;;=EENT^5^140
 ;;^UTILITY(U,$J,358.4,1253,0)
 ;;=MUSCULOSKELETAL^14^140
 ;;^UTILITY(U,$J,358.4,1254,0)
 ;;=NEURO^15^140
 ;;^UTILITY(U,$J,358.4,1255,0)
 ;;=MENTAL HEALTH^13^140
 ;;^UTILITY(U,$J,358.4,1256,0)
 ;;=GASTROENTEROLOGY^7^140
 ;;^UTILITY(U,$J,358.4,1257,0)
 ;;=GU / RENAL^8^140
 ;;^UTILITY(U,$J,358.4,1258,0)
 ;;=WOMEN'S HEALTH^21^140
 ;;^UTILITY(U,$J,358.4,1259,0)
 ;;=HEMATOLOGY/ONCOLOGY^9^140
 ;;^UTILITY(U,$J,358.4,1260,0)
 ;;=INFECTIOUS DISEASE^11^140
 ;;^UTILITY(U,$J,358.4,1261,0)
 ;;=DERMATOLOGY^4^140
 ;;^UTILITY(U,$J,358.4,1262,0)
 ;;=HISTORY OF ILLNESS^10^140
 ;;^UTILITY(U,$J,358.4,1263,0)
 ;;=PREVENTIVE HEALTH/SCREENINGS^1^140
 ;;^UTILITY(U,$J,358.4,1264,0)
 ;;=INJURY/TRAUMA^12^140
 ;;^UTILITY(U,$J,358.4,1265,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^20^140
 ;;^UTILITY(U,$J,358.4,1266,0)
 ;;=SEXUAL TRAUMA^19^140
 ;;^UTILITY(U,$J,358.4,1267,0)
 ;;=PAIN^17^140
 ;;^UTILITY(U,$J,358.4,1268,0)
 ;;=OTHER REASONS^16^140
 ;;^UTILITY(U,$J,358.4,1269,0)
 ;;=CAUSES OF INJURY (SECONDARY ONLY)^3^140
 ;;^UTILITY(U,$J,358.4,1270,0)
 ;;=ESOPHAGUS^4^141
 ;;^UTILITY(U,$J,358.4,1271,0)
 ;;=LYMPH NODES (SECONDARY)^6.5^141
 ;;^UTILITY(U,$J,358.4,1272,0)
 ;;=LARYNX^6.4^141
 ;;^UTILITY(U,$J,358.4,1273,0)
 ;;=LUNG^6.41^141
 ;;^UTILITY(U,$J,358.4,1274,0)
 ;;=MELANOMA^6.6^141
 ;;^UTILITY(U,$J,358.4,1275,0)
 ;;=GENITOURINARY^.5^141
 ;;^UTILITY(U,$J,358.4,1276,0)
 ;;=BRAIN^.7^141
 ;;^UTILITY(U,$J,358.4,1277,0)
 ;;=BREAST-FEMALE^.6^141
 ;;^UTILITY(U,$J,358.4,1278,0)
 ;;=HYPOPHARYNX^6.1^141
 ;;^UTILITY(U,$J,358.4,1279,0)
 ;;=CONNECTIVE & SOFT TISSUE^2^141
 ;;^UTILITY(U,$J,358.4,1280,0)
 ;;=RADIATION FOLLOW-UP^.45^141
 ;;^UTILITY(U,$J,358.4,1281,0)
 ;;=MOUTH^8^141
 ;;^UTILITY(U,$J,358.4,1282,0)
 ;;=MOUTH-FLOOR^9^141
 ;;^UTILITY(U,$J,358.4,1283,0)
 ;;=NASOPHARYNX^10^141
 ;;^UTILITY(U,$J,358.4,1284,0)
 ;;=OROPHARYNX^11^141
 ;;^UTILITY(U,$J,358.4,1285,0)
 ;;=PANCREAS^12^141
 ;;^UTILITY(U,$J,358.4,1286,0)
 ;;=RECTUM/ANUS^13^141
 ;;^UTILITY(U,$J,358.4,1287,0)
 ;;=SALIVARY GLANDS^14^141
 ;;^UTILITY(U,$J,358.4,1288,0)
 ;;=SECONDARY MALIGNANT NEOPLASMS^15^141
 ;;^UTILITY(U,$J,358.4,1289,0)
 ;;=TONGUE^16^141
 ;;^UTILITY(U,$J,358.4,1290,0)
 ;;=MISCELLANEOUS^18^141
 ;;^UTILITY(U,$J,358.4,1291,0)
 ;;=BENIGN NEOPLASMS^.47^141
 ;;^UTILITY(U,$J,358.4,1292,0)
 ;;=RADIATION TREATMENT^.2^141
 ;;^UTILITY(U,$J,358.4,1293,0)
 ;;=PERSONAL HISTORY CA^19^141
 ;;^UTILITY(U,$J,358.4,1294,0)
 ;;=FOLLOW-UP^2^142
 ;;^UTILITY(U,$J,358.4,1295,0)
 ;;=CONSULTATIONS^1^142
 ;;^UTILITY(U,$J,358.4,1296,0)
 ;;=NURSING^4^142
 ;;^UTILITY(U,$J,358.4,1297,0)
 ;;=NEW PATIENT^3^142
 ;;^UTILITY(U,$J,358.4,1298,0)
 ;;=TREATMENT PLANNING^1^143
 ;;^UTILITY(U,$J,358.4,1299,0)
 ;;=SIMULATION^2^143
 ;;^UTILITY(U,$J,358.4,1300,0)
 ;;=TREATMENT DEVICES^3^143
 ;;^UTILITY(U,$J,358.4,1301,0)
 ;;=DOSIMETRY CALCULATIONS^4^143
 ;;^UTILITY(U,$J,358.4,1302,0)
 ;;=TELETHERAPY ISODOSE PLAN^5^143
 ;;^UTILITY(U,$J,358.4,1303,0)
 ;;=WEEKLY TX MANAGEMENT^6^143
 ;;^UTILITY(U,$J,358.4,1304,0)
 ;;=MISCELLANEOUS^7^143
 ;;^UTILITY(U,$J,358.4,1305,0)
 ;;=IMRT PLAN^4.5^143
 ;;^UTILITY(U,$J,358.4,1306,0)
 ;;=TREATMENT DELIVERY^8^143
 ;;^UTILITY(U,$J,358.4,1307,0)
 ;;=BRACHYTHERAPY ISODOSE PLAN^4.75^143
 ;;^UTILITY(U,$J,358.4,1308,0)
 ;;=NEW PATIENT^2^144
 ;;^UTILITY(U,$J,358.4,1309,0)
 ;;=ESTABLISHED PATIENT^1^144
 ;;^UTILITY(U,$J,358.4,1310,0)
 ;;=CONSULTATIONS^3^144
 ;;^UTILITY(U,$J,358.4,1311,0)
 ;;=THERAPY MODALITIES/PROCEDURES^2^145
 ;;^UTILITY(U,$J,358.4,1312,0)
 ;;=INJECTIONS/DRUGS^6^145
 ;;^UTILITY(U,$J,358.4,1313,0)
 ;;=ORTHOTIC DEVICES^9^145
 ;;^UTILITY(U,$J,358.4,1314,0)
 ;;=KINESIOTHERAPY^7^145
 ;;^UTILITY(U,$J,358.4,1315,0)
 ;;=THERAPY EVALUATIONS^1^145
 ;;^UTILITY(U,$J,358.4,1316,0)
 ;;=WOUND CARE^11^145
 ;;^UTILITY(U,$J,358.4,1317,0)
 ;;=CARDIAC REHAB^3^145
 ;;^UTILITY(U,$J,358.4,1318,0)
 ;;=EDUCATION/TRAINING^4^145
 ;;^UTILITY(U,$J,358.4,1319,0)
 ;;=HOME THERAPY SERVICES^5^145
 ;;^UTILITY(U,$J,358.4,1320,0)
 ;;=NEUROMUSCULAR TESTING^8^145
 ;;^UTILITY(U,$J,358.4,1321,0)
 ;;=TEAM CONFERENCE^10^145
 ;;^UTILITY(U,$J,358.4,1322,0)
 ;;=FUNCTIONAL RPTING BODY POSITION^12^145
 ;;^UTILITY(U,$J,358.4,1323,0)
 ;;=FUNCTIONAL RPTING CARRY OBJECTS^13^145
 ;;^UTILITY(U,$J,358.4,1324,0)
 ;;=FUNCTIONAL RPTING MOBILITY^14^145
 ;;^UTILITY(U,$J,358.4,1325,0)
 ;;=FUNCTIONAL RPTING OTH PT/OT PRI^15^145
 ;;^UTILITY(U,$J,358.4,1326,0)
 ;;=FUNCTIONAL RPTING OTH PT/OT SUB^16^145
 ;;^UTILITY(U,$J,358.4,1327,0)
 ;;=FUNCTIONAL RPTING SELF CARE^17^145
 ;;^UTILITY(U,$J,358.4,1328,0)
 ;;=PRIMARY DIAGNOSES^1^146
 ;;^UTILITY(U,$J,358.4,1329,0)
 ;;=V CODES ^1^147
 ;;^UTILITY(U,$J,358.4,1330,0)
 ;;=AMPUTATION STATUS^2^147
 ;;^UTILITY(U,$J,358.4,1331,0)
 ;;=BRAIN DISORDERS^3^147
 ;;^UTILITY(U,$J,358.4,1332,0)
 ;;=CARDIOPULMONARY^4^147
 ;;^UTILITY(U,$J,358.4,1333,0)
 ;;=COMPLICATION DUE TO^5^147
 ;;^UTILITY(U,$J,358.4,1334,0)
 ;;=FRACTURES-LATE EFFECTS^6^147
 ;;^UTILITY(U,$J,358.4,1335,0)
 ;;=MENTAL DISORDERS^7^147
 ;;^UTILITY(U,$J,358.4,1336,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^8^147
 ;;^UTILITY(U,$J,358.4,1337,0)
 ;;=TERTIARY DX-TBI CODES^10^147
 ;;^UTILITY(U,$J,358.4,1338,0)
 ;;=QUATERNARY DX-POLYTRAUMA/TBI V-CODE^9^147
 ;;^UTILITY(U,$J,358.4,1339,0)
 ;;=ASPIRATION/INJECTION^1^148
 ;;^UTILITY(U,$J,358.4,1340,0)
 ;;=INJECTION MEDICATIONS^2^148
